tiprankstipranks
Trending News
More News >
GlaxoSmithKline Pharmaceuticals Limited (IN:GLAXO)
:GLAXO
India Market

GlaxoSmithKline Pharmaceuticals Limited (GLAXO) Income Statement

Compare
5 Followers

GlaxoSmithKline Pharmaceuticals Limited Income Statement

Last quarter (Q1 2026), GlaxoSmithKline Pharmaceuticals Limited's total revenue was ₹8.05B, a decrease of -1.16% from the same quarter last year. In Q1, GlaxoSmithKline Pharmaceuticals Limited's net income was ₹2.05B. See GlaxoSmithKline Pharmaceuticals Limited’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
₹ 37.49B₹ 34.54B₹ 32.52B₹ 32.78B₹ 29.26B
Gross Profit
₹ 23.35B₹ 20.99B₹ 19.48B₹ 19.00B₹ 16.43B
Operating Expenses
₹ 7.04B₹ 7.38B₹ 7.08B₹ 7.42B₹ 6.88B
Depreciation and Amortization
₹ 383.57M₹ 415.36M₹ 399.67M₹ 439.60M₹ 537.22M
EBITDA
₹ 11.53B₹ 8.81B₹ 7.88B₹ 7.43B₹ 5.73B
Operating Income
₹ 16.31B₹ 13.60B₹ 12.39B₹ 11.58B₹ 9.56B
Other Income/Expenses
₹ -3.71B₹ -5.44B₹ -4.03B₹ -3.79B₹ -5.02B
Pretax Income
₹ 12.60B₹ 8.16B₹ 8.36B₹ 7.79B₹ 4.54B
Net Income
₹ 9.28B₹ 5.90B₹ 6.11B₹ 16.95B₹ 3.58B
Per Share Metrics
Basic EPS
₹ 54.76₹ 34.83₹ 35.87₹ 21.27₹ 16.96
Diluted EPS
₹ 54.76₹ 34.83₹ 35.87₹ 22.48₹ 16.96
Weighted Average Shares Outstanding
169.41M 169.41M 170.25M 178.98M 169.41M
Weighted Average Shares Outstanding (Diluted)
169.41M 169.41M 169.41M 169.41M 169.41M
Currency in INR

GlaxoSmithKline Pharmaceuticals Limited Earnings and Revenue History